Tim Wentworth, the brand new CEO of Walgreens Boots Alliance, is changing the corporate’s most sensible healthcare products and services government as a part of a sequence of broader management strikes.

John Driscoll, who joined Chicagoland-based Walgreens Boots in 2022 after the corporate purchased homecare undertaking CareCentrix, will step down from his position as president of U.S. healthcare April 1 and be succeeded by means of former Solera Well being CEO Mary Langowski. In a submitting with the U.S. Securities and Change Fee, Walgreens mentioned that it expects Driscoll will keep on as a expert “for a restricted time period.”

Langowski has been CEO of Solera Well being, a controlled products and services group that markets engagement-focused applied sciences to payers and employers, since 2020. Ahead of that, she used to be leader technique and company construction officer at CVS Well being from 2014 to 2016, paintings that helped set the level for that corporate’s acquire of Aetna.

“I’ve had the danger to collaborate with John Driscoll and the Walgreens staff for a number of years, and I’m getting into this new bankruptcy fascinated by the alternatives forward,” Langwoski wrote in a publish on LinkedIn. “Healthcare wishes extra of the believe, comfort and private connection American citizens have with Walgreens. I’m having a look ahead to running along Tim, this dynamic staff, and our rising community of payer, supplier, well being machine and pharma companions to force higher well being for sufferers. I’m additionally extremely appreciative of the continuing reinforce and partnership from John.”

Along Langowski’s hiring, Wentworth ultimate week additionally introduced that intervening time CFO Manmohan Mahajan has taken on that position in a full-time capability and mentioned that Elizabeth Burger will sign up for his staff as leader human sources officer subsequent month after preserving the similar position at production firms FlowServe and HanesBrands.

Walgreens’ healthcare products and services workforce rang up revenues of $1.9 billion within the corporate’s most up-to-date fiscal quarter and posted an EBITDA lack of about $39 million. The corporate’s leaders are forecasting that the unit, which accommodates CareCentrix in addition to the Shields strong point pharmacy and a big funding within the VillageMD retail health facility chain, will damage even this yr on an adjusted EBITDA foundation.